March 25, 2024Open Access

Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic

Key Points

Key points are not available for this paper at this time.

Abstract

We studied whether the use of hydroxychloroquine (HCQ) for COVID-19 resulted in supply shortages for patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Mercadé‐Besora et al. (Mon,) studied this question.

synapsesocial.com/papers/68e72857b6db6435876a1d85 https://doi.org/https://doi.org/10.1002/acr.25331

KI fragen

Bookmark

View Full Paper